Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vascular Surgical Procedures | 28 | 2021 | 1489 | 3.590 |
Why?
|
Arteriovenous Shunt, Surgical | 12 | 2023 | 290 | 2.660 |
Why?
|
Graft Occlusion, Vascular | 16 | 2024 | 537 | 2.530 |
Why?
|
Veins | 20 | 2024 | 767 | 2.500 |
Why?
|
Carotid Stenosis | 12 | 2021 | 859 | 2.210 |
Why?
|
Diet, Protein-Restricted | 5 | 2020 | 72 | 2.190 |
Why?
|
Carotid Artery, Common | 9 | 2020 | 175 | 2.030 |
Why?
|
Tunica Intima | 14 | 2021 | 458 | 1.980 |
Why?
|
Vena Cava, Inferior | 7 | 2021 | 459 | 1.910 |
Why?
|
Caloric Restriction | 8 | 2021 | 299 | 1.890 |
Why?
|
Vascular Patency | 20 | 2023 | 911 | 1.570 |
Why?
|
Blood Vessel Prosthesis | 18 | 2023 | 951 | 1.480 |
Why?
|
Endarterectomy, Carotid | 8 | 2019 | 554 | 1.440 |
Why?
|
Renal Dialysis | 15 | 2024 | 1796 | 1.350 |
Why?
|
Blood Vessel Prosthesis Implantation | 17 | 2023 | 1425 | 1.330 |
Why?
|
Preoperative Care | 7 | 2019 | 2242 | 1.220 |
Why?
|
Arteriovenous Fistula | 5 | 2024 | 319 | 1.160 |
Why?
|
Vascular Grafting | 7 | 2024 | 162 | 1.120 |
Why?
|
Subcutaneous Fat | 4 | 2014 | 393 | 1.110 |
Why?
|
Aortic Aneurysm, Abdominal | 15 | 2022 | 1228 | 1.010 |
Why?
|
Neointima | 5 | 2020 | 133 | 0.940 |
Why?
|
Peripheral Arterial Disease | 10 | 2024 | 1274 | 0.930 |
Why?
|
Lower Extremity | 10 | 2018 | 1201 | 0.900 |
Why?
|
Hyperplasia | 19 | 2021 | 1150 | 0.890 |
Why?
|
Radial Artery | 4 | 2022 | 187 | 0.860 |
Why?
|
Cystathionine gamma-Lyase | 4 | 2020 | 36 | 0.800 |
Why?
|
Hydrogen Sulfide | 7 | 2021 | 141 | 0.780 |
Why?
|
Surgical Wound Dehiscence | 3 | 2017 | 212 | 0.760 |
Why?
|
Methionine | 3 | 2024 | 570 | 0.750 |
Why?
|
Wound Healing | 11 | 2021 | 2801 | 0.730 |
Why?
|
Carotid Arteries | 13 | 2023 | 941 | 0.730 |
Why?
|
Jugular Veins | 6 | 2009 | 210 | 0.700 |
Why?
|
Interleukin-1 | 4 | 2012 | 1250 | 0.670 |
Why?
|
Surgical Wound Infection | 7 | 2021 | 1530 | 0.660 |
Why?
|
Bandages | 2 | 2014 | 269 | 0.660 |
Why?
|
Polyesters | 2 | 2014 | 371 | 0.660 |
Why?
|
Leg | 7 | 2013 | 1087 | 0.640 |
Why?
|
Polyethylenes | 2 | 2014 | 290 | 0.630 |
Why?
|
Blood Vessels | 3 | 2018 | 1111 | 0.620 |
Why?
|
Graft Survival | 10 | 2021 | 3841 | 0.610 |
Why?
|
Peripheral Vascular Diseases | 5 | 2013 | 488 | 0.580 |
Why?
|
Hindlimb | 2 | 2018 | 513 | 0.580 |
Why?
|
Ultrasonography, Doppler, Duplex | 3 | 2022 | 198 | 0.570 |
Why?
|
Specialty Boards | 1 | 2019 | 235 | 0.570 |
Why?
|
Adiponectin | 4 | 2016 | 1106 | 0.570 |
Why?
|
Reperfusion Injury | 4 | 2018 | 1026 | 0.560 |
Why?
|
Brachial Artery | 2 | 2023 | 366 | 0.560 |
Why?
|
Hemodynamics | 7 | 2014 | 4164 | 0.540 |
Why?
|
Tumor Necrosis Factor-alpha | 7 | 2013 | 4340 | 0.530 |
Why?
|
Adipose Tissue | 6 | 2021 | 3309 | 0.530 |
Why?
|
Limb Salvage | 7 | 2024 | 480 | 0.520 |
Why?
|
Upper Extremity | 2 | 2019 | 658 | 0.510 |
Why?
|
Microscopy, Acoustic | 2 | 2013 | 47 | 0.510 |
Why?
|
Time Factors | 40 | 2023 | 39953 | 0.500 |
Why?
|
Forearm | 3 | 2024 | 427 | 0.500 |
Why?
|
Silver Compounds | 1 | 2014 | 23 | 0.480 |
Why?
|
Ischemia | 11 | 2018 | 1889 | 0.480 |
Why?
|
Alginates | 2 | 2022 | 248 | 0.470 |
Why?
|
Silk | 1 | 2014 | 90 | 0.450 |
Why?
|
Matrix Metalloproteinase 2 | 3 | 2009 | 459 | 0.440 |
Why?
|
Inflammation Mediators | 6 | 2015 | 1885 | 0.430 |
Why?
|
Vascular System Injuries | 1 | 2017 | 246 | 0.430 |
Why?
|
Delivery of Health Care, Integrated | 3 | 2021 | 940 | 0.430 |
Why?
|
Disease Models, Animal | 16 | 2021 | 18217 | 0.430 |
Why?
|
Matrix Metalloproteinase 9 | 4 | 2012 | 631 | 0.420 |
Why?
|
Elastin | 1 | 2014 | 298 | 0.410 |
Why?
|
Biomimetic Materials | 1 | 2014 | 172 | 0.410 |
Why?
|
Receptors, Interleukin-1 Type I | 1 | 2012 | 30 | 0.410 |
Why?
|
Femoral Artery | 7 | 2021 | 826 | 0.410 |
Why?
|
Mice, Inbred C57BL | 20 | 2024 | 22129 | 0.400 |
Why?
|
Hemorheology | 3 | 2011 | 144 | 0.400 |
Why?
|
Tunica Media | 1 | 2012 | 110 | 0.400 |
Why?
|
Cytokines | 4 | 2021 | 7386 | 0.400 |
Why?
|
Anti-Infective Agents, Local | 1 | 2014 | 247 | 0.390 |
Why?
|
Arterial Occlusive Diseases | 7 | 2019 | 749 | 0.390 |
Why?
|
Polytetrafluoroethylene | 5 | 2023 | 245 | 0.390 |
Why?
|
Interdisciplinary Communication | 2 | 2019 | 928 | 0.390 |
Why?
|
Uremia | 1 | 2012 | 202 | 0.380 |
Why?
|
Regional Blood Flow | 8 | 2017 | 1498 | 0.370 |
Why?
|
Rabbits | 16 | 2015 | 4749 | 0.370 |
Why?
|
Male | 94 | 2024 | 360675 | 0.360 |
Why?
|
Animals | 61 | 2024 | 168083 | 0.350 |
Why?
|
Comparative Effectiveness Research | 3 | 2023 | 709 | 0.340 |
Why?
|
Hyperglycemia | 1 | 2018 | 1375 | 0.340 |
Why?
|
Endovascular Procedures | 9 | 2022 | 2181 | 0.340 |
Why?
|
Adaptation, Physiological | 4 | 2012 | 1301 | 0.340 |
Why?
|
Health Priorities | 1 | 2013 | 375 | 0.340 |
Why?
|
Leptin | 6 | 2021 | 1595 | 0.330 |
Why?
|
Patient Care Team | 2 | 2019 | 2513 | 0.320 |
Why?
|
Treatment Outcome | 39 | 2023 | 64670 | 0.310 |
Why?
|
Amputation Stumps | 1 | 2008 | 38 | 0.310 |
Why?
|
Ferric Compounds | 1 | 2010 | 378 | 0.310 |
Why?
|
Dietary Fats | 2 | 2013 | 1995 | 0.310 |
Why?
|
Length of Stay | 8 | 2021 | 6420 | 0.310 |
Why?
|
Iliac Artery | 4 | 2019 | 343 | 0.310 |
Why?
|
Resistin | 3 | 2013 | 172 | 0.300 |
Why?
|
Magnetics | 1 | 2010 | 598 | 0.290 |
Why?
|
Blood Flow Velocity | 7 | 2017 | 1374 | 0.280 |
Why?
|
Education, Medical, Graduate | 1 | 2019 | 2372 | 0.280 |
Why?
|
Forefoot, Human | 1 | 2006 | 31 | 0.270 |
Why?
|
Fibroblasts | 3 | 2017 | 4137 | 0.270 |
Why?
|
Proteins | 1 | 2021 | 5993 | 0.270 |
Why?
|
Cardiovascular Agents | 1 | 2013 | 842 | 0.270 |
Why?
|
Interleukin-10 | 4 | 2007 | 1176 | 0.270 |
Why?
|
Carotid Artery Diseases | 3 | 2014 | 877 | 0.270 |
Why?
|
Aged | 51 | 2024 | 169266 | 0.260 |
Why?
|
Stents | 2 | 2018 | 3177 | 0.260 |
Why?
|
Mice | 30 | 2024 | 81324 | 0.260 |
Why?
|
Collagen | 1 | 2014 | 2635 | 0.260 |
Why?
|
Vascular Diseases | 2 | 2013 | 1160 | 0.250 |
Why?
|
Reoperation | 8 | 2023 | 4304 | 0.240 |
Why?
|
RNA, Messenger | 8 | 2012 | 12743 | 0.240 |
Why?
|
Inflammation | 3 | 2014 | 10758 | 0.240 |
Why?
|
Shear Strength | 5 | 2009 | 160 | 0.240 |
Why?
|
Patient Discharge | 3 | 2016 | 3441 | 0.240 |
Why?
|
Plasminogen Activator Inhibitor 1 | 3 | 2013 | 278 | 0.230 |
Why?
|
Stroke | 5 | 2015 | 9720 | 0.230 |
Why?
|
Cell Movement | 4 | 2015 | 5195 | 0.230 |
Why?
|
Prosthesis-Related Infections | 4 | 2021 | 488 | 0.230 |
Why?
|
Hospitals, Veterans | 1 | 2006 | 395 | 0.230 |
Why?
|
Humans | 99 | 2024 | 761098 | 0.230 |
Why?
|
Female | 69 | 2024 | 392458 | 0.220 |
Why?
|
Chi-Square Distribution | 5 | 2017 | 3419 | 0.220 |
Why?
|
Risk Factors | 32 | 2024 | 74219 | 0.220 |
Why?
|
Diet | 4 | 2021 | 8047 | 0.220 |
Why?
|
Middle Aged | 52 | 2024 | 220835 | 0.220 |
Why?
|
Mice, Knockout | 12 | 2021 | 14393 | 0.220 |
Why?
|
Neovascularization, Physiologic | 4 | 2018 | 1347 | 0.210 |
Why?
|
Prospective Studies | 22 | 2022 | 54419 | 0.210 |
Why?
|
Saphenous Vein | 4 | 2015 | 516 | 0.210 |
Why?
|
Boston | 5 | 2021 | 9324 | 0.210 |
Why?
|
Groin | 2 | 2021 | 106 | 0.200 |
Why?
|
Pancreatic Elastase | 2 | 2021 | 126 | 0.200 |
Why?
|
Postoperative Complications | 14 | 2022 | 15634 | 0.200 |
Why?
|
Osteomyelitis | 1 | 2006 | 407 | 0.200 |
Why?
|
Macrophages | 7 | 2024 | 5754 | 0.200 |
Why?
|
Patient Readmission | 6 | 2021 | 3268 | 0.200 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 2 | 2017 | 151 | 0.200 |
Why?
|
Arteries | 3 | 2006 | 1121 | 0.200 |
Why?
|
Polyethylene Terephthalates | 4 | 1995 | 112 | 0.190 |
Why?
|
Stress, Mechanical | 4 | 2013 | 1674 | 0.190 |
Why?
|
Gadolinium DTPA | 2 | 2018 | 823 | 0.190 |
Why?
|
Energy Intake | 3 | 2021 | 2133 | 0.190 |
Why?
|
Captopril | 1 | 2021 | 262 | 0.190 |
Why?
|
Nutritional Status | 2 | 2020 | 1597 | 0.190 |
Why?
|
Phenotype | 3 | 2014 | 16572 | 0.180 |
Why?
|
Receptors, Tumor Necrosis Factor | 2 | 2005 | 585 | 0.180 |
Why?
|
Societies, Medical | 1 | 2013 | 3923 | 0.180 |
Why?
|
Diet Therapy | 1 | 2021 | 151 | 0.180 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 3 | 2007 | 255 | 0.180 |
Why?
|
Up-Regulation | 2 | 2007 | 4111 | 0.180 |
Why?
|
Immunity, Innate | 1 | 2012 | 3044 | 0.180 |
Why?
|
Endarterectomy | 1 | 2021 | 196 | 0.170 |
Why?
|
Databases, Factual | 6 | 2023 | 7969 | 0.170 |
Why?
|
Systems Analysis | 1 | 2021 | 169 | 0.170 |
Why?
|
Models, Animal | 4 | 2010 | 2114 | 0.170 |
Why?
|
PPAR alpha | 1 | 2021 | 175 | 0.170 |
Why?
|
Bilophila | 1 | 2019 | 12 | 0.170 |
Why?
|
Diet, Vegetarian | 1 | 2021 | 180 | 0.170 |
Why?
|
Receptors, LDL | 2 | 2020 | 489 | 0.170 |
Why?
|
Malaria, Cerebral | 1 | 2021 | 136 | 0.170 |
Why?
|
Cholesterol, Dietary | 1 | 2020 | 224 | 0.170 |
Why?
|
Enzyme Induction | 1 | 2020 | 452 | 0.160 |
Why?
|
Wrist | 1 | 2021 | 226 | 0.160 |
Why?
|
Ligation | 5 | 2021 | 446 | 0.160 |
Why?
|
Hospital Costs | 2 | 2016 | 947 | 0.160 |
Why?
|
Obesity | 4 | 2014 | 12937 | 0.160 |
Why?
|
Magnetic Resonance Angiography | 2 | 2011 | 1432 | 0.160 |
Why?
|
After-Hours Care | 1 | 2019 | 102 | 0.160 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2021 | 156 | 0.160 |
Why?
|
Adipose Tissue, Brown | 1 | 2024 | 763 | 0.160 |
Why?
|
Nanoparticles | 1 | 2010 | 1959 | 0.160 |
Why?
|
Endothelial Cells | 5 | 2018 | 3550 | 0.160 |
Why?
|
Amino Acids, Sulfur | 1 | 2018 | 16 | 0.150 |
Why?
|
Parasites | 1 | 2021 | 160 | 0.150 |
Why?
|
Retrospective Studies | 31 | 2024 | 80673 | 0.150 |
Why?
|
Chemokine CCL2 | 3 | 2013 | 602 | 0.150 |
Why?
|
Cerebral Angiography | 2 | 2014 | 1281 | 0.150 |
Why?
|
Multivariate Analysis | 10 | 2017 | 12058 | 0.150 |
Why?
|
Muscle, Smooth, Vascular | 4 | 2015 | 1488 | 0.150 |
Why?
|
Lipoproteins, VLDL | 1 | 2018 | 201 | 0.150 |
Why?
|
Laser-Doppler Flowmetry | 2 | 2012 | 239 | 0.150 |
Why?
|
Activating Transcription Factor 4 | 1 | 2018 | 84 | 0.150 |
Why?
|
Kaplan-Meier Estimate | 8 | 2017 | 6482 | 0.150 |
Why?
|
Aged, 80 and over | 17 | 2020 | 58946 | 0.150 |
Why?
|
Tumor Necrosis Factor Decoy Receptors | 2 | 2007 | 8 | 0.150 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2019 | 392 | 0.140 |
Why?
|
Risk Reduction Behavior | 2 | 2014 | 1111 | 0.140 |
Why?
|
Biomedical Research | 1 | 2013 | 3429 | 0.140 |
Why?
|
Pilot Projects | 4 | 2019 | 8639 | 0.140 |
Why?
|
Device Removal | 2 | 2018 | 630 | 0.140 |
Why?
|
Seroma | 1 | 2017 | 73 | 0.140 |
Why?
|
Models, Cardiovascular | 3 | 2008 | 983 | 0.140 |
Why?
|
Phlebotomy | 2 | 2008 | 137 | 0.140 |
Why?
|
Administration, Topical | 2 | 2019 | 703 | 0.140 |
Why?
|
Transplants | 2 | 2009 | 206 | 0.130 |
Why?
|
Kidney Failure, Chronic | 4 | 2021 | 2478 | 0.130 |
Why?
|
Neovascularization, Pathologic | 2 | 2018 | 2635 | 0.130 |
Why?
|
Hypertension, Portal | 2 | 1989 | 227 | 0.130 |
Why?
|
Intermittent Claudication | 2 | 2015 | 304 | 0.130 |
Why?
|
Aortic Diseases | 2 | 2018 | 735 | 0.130 |
Why?
|
Small Molecule Libraries | 1 | 2021 | 731 | 0.130 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2018 | 546 | 0.130 |
Why?
|
Intraoperative Care | 1 | 2019 | 767 | 0.130 |
Why?
|
Immunity | 1 | 2021 | 996 | 0.130 |
Why?
|
Hematoma | 3 | 2017 | 763 | 0.130 |
Why?
|
Odds Ratio | 8 | 2017 | 9648 | 0.120 |
Why?
|
Amino Acids | 1 | 2021 | 1703 | 0.120 |
Why?
|
Ultrasonography, Doppler, Pulsed | 1 | 2014 | 19 | 0.120 |
Why?
|
Frail Elderly | 1 | 2020 | 765 | 0.120 |
Why?
|
Comprehension | 1 | 2020 | 619 | 0.120 |
Why?
|
Aneurysm, False | 1 | 2017 | 255 | 0.120 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 1504 | 0.120 |
Why?
|
Ciprofloxacin | 2 | 1993 | 312 | 0.120 |
Why?
|
Connexin 43 | 1 | 2015 | 200 | 0.120 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2015 | 1650 | 0.120 |
Why?
|
Hexuronic Acids | 1 | 2014 | 145 | 0.120 |
Why?
|
Glucuronic Acid | 1 | 2014 | 150 | 0.120 |
Why?
|
Age Factors | 6 | 2014 | 18385 | 0.120 |
Why?
|
Risk Assessment | 15 | 2023 | 24013 | 0.120 |
Why?
|
Endothelium, Vascular | 3 | 2012 | 4421 | 0.120 |
Why?
|
Receptors, Purinergic P2Y1 | 1 | 2014 | 40 | 0.110 |
Why?
|
Informed Consent | 1 | 2020 | 1007 | 0.110 |
Why?
|
Phenols | 1 | 2017 | 517 | 0.110 |
Why?
|
Foot Ulcer | 1 | 2014 | 62 | 0.110 |
Why?
|
Apoptosis | 3 | 2007 | 9478 | 0.110 |
Why?
|
Cell Proliferation | 5 | 2015 | 10421 | 0.110 |
Why?
|
Liver | 4 | 2018 | 7513 | 0.110 |
Why?
|
Plant Lectins | 1 | 1993 | 103 | 0.110 |
Why?
|
Anastomosis, Surgical | 4 | 2012 | 982 | 0.110 |
Why?
|
Texas | 1 | 2014 | 403 | 0.110 |
Why?
|
Intention to Treat Analysis | 1 | 2014 | 413 | 0.110 |
Why?
|
Edema | 1 | 2017 | 765 | 0.110 |
Why?
|
Autophagy | 1 | 2021 | 1326 | 0.110 |
Why?
|
Glycoconjugates | 1 | 1993 | 88 | 0.110 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2017 | 700 | 0.110 |
Why?
|
History, 21st Century | 1 | 2019 | 1566 | 0.110 |
Why?
|
Gene Expression | 4 | 2012 | 7567 | 0.110 |
Why?
|
Aorta, Thoracic | 2 | 2024 | 1096 | 0.110 |
Why?
|
Adenosine Diphosphate | 1 | 2014 | 422 | 0.100 |
Why?
|
Emergencies | 1 | 2019 | 1217 | 0.100 |
Why?
|
Feces | 1 | 2019 | 1490 | 0.100 |
Why?
|
Aorta, Abdominal | 3 | 2012 | 625 | 0.100 |
Why?
|
Subclavian Artery | 1 | 2013 | 133 | 0.100 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2018 | 1116 | 0.100 |
Why?
|
Liver Transplantation | 3 | 2010 | 2329 | 0.100 |
Why?
|
Radiography, Interventional | 1 | 2019 | 1122 | 0.100 |
Why?
|
Tissue Engineering | 2 | 2022 | 1865 | 0.100 |
Why?
|
Stress, Physiological | 3 | 2017 | 1406 | 0.100 |
Why?
|
Prostheses and Implants | 2 | 2018 | 1276 | 0.100 |
Why?
|
Patient Selection | 6 | 2018 | 4245 | 0.100 |
Why?
|
Efficiency, Organizational | 1 | 2016 | 695 | 0.100 |
Why?
|
Plaque, Atherosclerotic | 3 | 2018 | 1535 | 0.100 |
Why?
|
Workflow | 1 | 2016 | 850 | 0.100 |
Why?
|
Platelet Activation | 1 | 1995 | 646 | 0.100 |
Why?
|
Cohort Studies | 9 | 2023 | 41486 | 0.100 |
Why?
|
Signal Transduction | 6 | 2015 | 23415 | 0.090 |
Why?
|
Antigens, CD | 1 | 2002 | 4008 | 0.090 |
Why?
|
Proportional Hazards Models | 6 | 2017 | 12467 | 0.090 |
Why?
|
Lectins | 1 | 1993 | 489 | 0.090 |
Why?
|
Mesenteric Vascular Occlusion | 2 | 2002 | 92 | 0.090 |
Why?
|
Popliteal Artery | 2 | 2012 | 310 | 0.090 |
Why?
|
Foot | 2 | 2014 | 575 | 0.090 |
Why?
|
History, 20th Century | 1 | 2019 | 2764 | 0.090 |
Why?
|
Cost Savings | 1 | 2016 | 912 | 0.090 |
Why?
|
Program Evaluation | 2 | 2016 | 2487 | 0.090 |
Why?
|
Organizational Objectives | 1 | 2013 | 426 | 0.090 |
Why?
|
Capillary Permeability | 1 | 2014 | 773 | 0.090 |
Why?
|
Triglycerides | 1 | 2018 | 2457 | 0.090 |
Why?
|
Delayed-Action Preparations | 2 | 2012 | 961 | 0.090 |
Why?
|
Ultrasonography, Interventional | 1 | 2019 | 1496 | 0.090 |
Why?
|
Homeostasis | 1 | 2021 | 3318 | 0.090 |
Why?
|
Fasting | 1 | 2017 | 1603 | 0.090 |
Why?
|
Hydrogen Peroxide | 1 | 2014 | 731 | 0.090 |
Why?
|
Cost-Benefit Analysis | 4 | 2016 | 5494 | 0.090 |
Why?
|
Polypharmacy | 1 | 2013 | 306 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2018 | 3493 | 0.090 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2014 | 495 | 0.090 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2010 | 120 | 0.090 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5841 | 0.090 |
Why?
|
Weight Loss | 1 | 2021 | 2680 | 0.090 |
Why?
|
Microvessels | 1 | 2014 | 580 | 0.090 |
Why?
|
Ampulla of Vater | 1 | 2010 | 149 | 0.090 |
Why?
|
Interleukin-8 | 1 | 2013 | 696 | 0.090 |
Why?
|
Dietary Proteins | 1 | 2015 | 951 | 0.090 |
Why?
|
Feasibility Studies | 2 | 2016 | 5249 | 0.080 |
Why?
|
Immunohistochemistry | 4 | 2007 | 11066 | 0.080 |
Why?
|
Lactose Synthase | 1 | 1989 | 1 | 0.080 |
Why?
|
Ultrasonography | 4 | 2012 | 5971 | 0.080 |
Why?
|
N-Acetyllactosamine Synthase | 1 | 1989 | 3 | 0.080 |
Why?
|
Kidney | 3 | 2014 | 7034 | 0.080 |
Why?
|
Glucose | 1 | 2021 | 4341 | 0.080 |
Why?
|
Principal Component Analysis | 1 | 2012 | 942 | 0.080 |
Why?
|
Indoles | 1 | 2017 | 1830 | 0.080 |
Why?
|
Carrier Proteins | 2 | 2021 | 4933 | 0.080 |
Why?
|
Hepatocyte Growth Factor | 1 | 2010 | 270 | 0.080 |
Why?
|
Toll-Like Receptors | 1 | 2012 | 575 | 0.080 |
Why?
|
Portal Vein | 2 | 1992 | 432 | 0.080 |
Why?
|
Contrast Media | 3 | 2018 | 5311 | 0.080 |
Why?
|
United States | 12 | 2021 | 72337 | 0.080 |
Why?
|
Health Services Research | 1 | 2016 | 1807 | 0.080 |
Why?
|
Hemorrhage | 2 | 2018 | 3422 | 0.080 |
Why?
|
Lipid Metabolism | 2 | 2018 | 1893 | 0.080 |
Why?
|
Diabetic Angiopathies | 1 | 2014 | 805 | 0.080 |
Why?
|
Mesenteric Veins | 1 | 1989 | 86 | 0.080 |
Why?
|
Prosthesis Failure | 2 | 2018 | 1204 | 0.080 |
Why?
|
Receptors, CCR2 | 1 | 2009 | 215 | 0.080 |
Why?
|
Ambulatory Care | 1 | 2019 | 2769 | 0.080 |
Why?
|
Research Support as Topic | 1 | 2013 | 697 | 0.080 |
Why?
|
Ferritins | 2 | 2008 | 597 | 0.080 |
Why?
|
Linear Models | 3 | 2014 | 5869 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 4565 | 0.080 |
Why?
|
Treatment Failure | 1 | 2014 | 2643 | 0.080 |
Why?
|
Comorbidity | 5 | 2014 | 10514 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 3 | 2018 | 36418 | 0.080 |
Why?
|
Activities of Daily Living | 2 | 2008 | 2420 | 0.070 |
Why?
|
Interleukins | 1 | 2013 | 782 | 0.070 |
Why?
|
Enzyme Activation | 1 | 2014 | 3577 | 0.070 |
Why?
|
Logistic Models | 4 | 2017 | 13254 | 0.070 |
Why?
|
Anesthesia | 1 | 2019 | 1591 | 0.070 |
Why?
|
Surface Properties | 1 | 2010 | 1162 | 0.070 |
Why?
|
Occlusive Dressings | 1 | 2007 | 52 | 0.070 |
Why?
|
Monocytes | 3 | 2006 | 2570 | 0.070 |
Why?
|
Varicose Veins | 1 | 1989 | 156 | 0.070 |
Why?
|
Pancreaticoduodenectomy | 1 | 2010 | 509 | 0.070 |
Why?
|
Apolipoproteins E | 1 | 2012 | 1443 | 0.070 |
Why?
|
Clinical Competence | 2 | 2020 | 4786 | 0.070 |
Why?
|
Thrombosis | 2 | 2019 | 2944 | 0.070 |
Why?
|
Transplantation, Autologous | 2 | 2010 | 2112 | 0.070 |
Why?
|
Bacteria | 1 | 2017 | 2190 | 0.070 |
Why?
|
Ileum | 1 | 1989 | 557 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2019 | 3603 | 0.070 |
Why?
|
Registries | 6 | 2021 | 8236 | 0.070 |
Why?
|
Reperfusion | 1 | 2007 | 271 | 0.070 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2757 | 0.060 |
Why?
|
Species Specificity | 1 | 2010 | 2406 | 0.060 |
Why?
|
Markov Chains | 3 | 2014 | 965 | 0.060 |
Why?
|
Enzyme Precursors | 1 | 2006 | 167 | 0.060 |
Why?
|
Curriculum | 1 | 2019 | 3739 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2020 | 4013 | 0.060 |
Why?
|
Case-Control Studies | 3 | 2017 | 22157 | 0.060 |
Why?
|
Intestine, Small | 2 | 1989 | 1207 | 0.060 |
Why?
|
Specimen Handling | 1 | 2010 | 701 | 0.060 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2009 | 630 | 0.060 |
Why?
|
Collagenases | 1 | 2006 | 222 | 0.060 |
Why?
|
Bacterial Infections | 1 | 1993 | 1390 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2870 | 0.060 |
Why?
|
Aortic Aneurysm, Thoracic | 2 | 2002 | 695 | 0.060 |
Why?
|
Dogs | 3 | 2001 | 3832 | 0.060 |
Why?
|
Exercise | 1 | 2021 | 5872 | 0.060 |
Why?
|
Lipopolysaccharides | 1 | 2012 | 2200 | 0.060 |
Why?
|
Myocytes, Smooth Muscle | 2 | 2021 | 698 | 0.060 |
Why?
|
Quality Improvement | 2 | 2019 | 3801 | 0.060 |
Why?
|
Rats | 3 | 2018 | 23713 | 0.060 |
Why?
|
Critical Illness | 5 | 2017 | 2709 | 0.060 |
Why?
|
Antihypertensive Agents | 1 | 2014 | 2019 | 0.060 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 2004 | 72 | 0.060 |
Why?
|
Immediate-Early Proteins | 1 | 2007 | 444 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2018 | 10213 | 0.060 |
Why?
|
Sex Factors | 3 | 2017 | 10552 | 0.060 |
Why?
|
Tumor Burden | 1 | 2010 | 1892 | 0.060 |
Why?
|
Transforming Growth Factor beta | 2 | 2012 | 1964 | 0.060 |
Why?
|
Debridement | 1 | 2006 | 493 | 0.060 |
Why?
|
Chronic Disease | 4 | 2014 | 9317 | 0.050 |
Why?
|
Cattle | 2 | 2023 | 3819 | 0.050 |
Why?
|
Receptors, Interleukin-1 | 1 | 2004 | 262 | 0.050 |
Why?
|
Cell Line | 2 | 2014 | 15542 | 0.050 |
Why?
|
Macrophage-1 Antigen | 1 | 2004 | 286 | 0.050 |
Why?
|
Interleukin-6 | 1 | 2013 | 3210 | 0.050 |
Why?
|
Acute Kidney Injury | 1 | 2015 | 1923 | 0.050 |
Why?
|
Binding Sites | 2 | 2010 | 5993 | 0.050 |
Why?
|
Urea | 2 | 2015 | 442 | 0.050 |
Why?
|
Microspheres | 2 | 2004 | 783 | 0.050 |
Why?
|
Amino Acid Sequence | 1 | 2014 | 13404 | 0.050 |
Why?
|
Disease Progression | 2 | 2012 | 13506 | 0.050 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2013 | 1394 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10755 | 0.050 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2014 | 2746 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 3689 | 0.050 |
Why?
|
Hypertension | 1 | 2021 | 8537 | 0.050 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 17598 | 0.050 |
Why?
|
Incidence | 4 | 2014 | 21357 | 0.050 |
Why?
|
Interleukin-1beta | 1 | 2007 | 1002 | 0.050 |
Why?
|
Angioplasty | 2 | 2021 | 356 | 0.050 |
Why?
|
Mesenteric Arteries | 2 | 2002 | 178 | 0.050 |
Why?
|
Indicators and Reagents | 1 | 2002 | 453 | 0.050 |
Why?
|
Gelatin | 1 | 2022 | 221 | 0.050 |
Why?
|
Arm | 1 | 2024 | 589 | 0.050 |
Why?
|
Catheters | 1 | 2024 | 426 | 0.050 |
Why?
|
Health Care Costs | 1 | 2014 | 3238 | 0.040 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2001 | 283 | 0.040 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2004 | 1128 | 0.040 |
Why?
|
Medical Records Systems, Computerized | 1 | 2006 | 1191 | 0.040 |
Why?
|
Recovery of Function | 2 | 2008 | 2981 | 0.040 |
Why?
|
Image Enhancement | 1 | 2011 | 2888 | 0.040 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2002 | 344 | 0.040 |
Why?
|
Catheters, Indwelling | 1 | 2002 | 426 | 0.040 |
Why?
|
Graft Rejection | 3 | 2012 | 4479 | 0.040 |
Why?
|
Follow-Up Studies | 11 | 2015 | 39121 | 0.040 |
Why?
|
Models, Economic | 2 | 2014 | 714 | 0.040 |
Why?
|
Femoral Vein | 1 | 2000 | 153 | 0.040 |
Why?
|
Organ Culture Techniques | 1 | 2021 | 793 | 0.040 |
Why?
|
Mice, Inbred Strains | 1 | 2002 | 1761 | 0.040 |
Why?
|
Body Mass Index | 1 | 2017 | 12951 | 0.040 |
Why?
|
Embolization, Therapeutic | 1 | 1989 | 1419 | 0.040 |
Why?
|
Luminescent Proteins | 1 | 2002 | 836 | 0.040 |
Why?
|
Bioprosthesis | 1 | 2023 | 591 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2013 | 3535 | 0.040 |
Why?
|
Survival Rate | 7 | 2012 | 12727 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2015 | 7844 | 0.040 |
Why?
|
Carotid Artery Thrombosis | 1 | 1998 | 50 | 0.040 |
Why?
|
Iron | 1 | 2007 | 1790 | 0.040 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2012 | 2254 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 13630 | 0.040 |
Why?
|
RNA Interference | 2 | 2018 | 2816 | 0.040 |
Why?
|
Connective Tissue Growth Factor | 2 | 2009 | 91 | 0.040 |
Why?
|
Angiography, Digital Subtraction | 1 | 1999 | 335 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6585 | 0.040 |
Why?
|
New England | 1 | 2021 | 1050 | 0.040 |
Why?
|
Dextrothyroxine | 1 | 2017 | 6 | 0.040 |
Why?
|
Adenoviridae | 1 | 2002 | 1084 | 0.040 |
Why?
|
Adipocytes | 1 | 2024 | 1184 | 0.040 |
Why?
|
Angiopoietin-2 | 1 | 2018 | 173 | 0.040 |
Why?
|
Hydrolysis | 1 | 2018 | 652 | 0.040 |
Why?
|
Cells, Cultured | 3 | 2021 | 18926 | 0.040 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2010 | 2293 | 0.040 |
Why?
|
Microfluidics | 1 | 2022 | 651 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2012 | 11856 | 0.040 |
Why?
|
Recombinant Proteins | 1 | 2007 | 6507 | 0.030 |
Why?
|
Hydrogels | 1 | 2022 | 720 | 0.030 |
Why?
|
Connexins | 1 | 2018 | 352 | 0.030 |
Why?
|
Lymphocytes | 1 | 2004 | 2603 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2014 | 7400 | 0.030 |
Why?
|
Aortography | 1 | 2018 | 421 | 0.030 |
Why?
|
Food | 1 | 2021 | 768 | 0.030 |
Why?
|
Apolipoproteins | 1 | 2018 | 327 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2002 | 2061 | 0.030 |
Why?
|
Immunoglobulin G | 2 | 2005 | 4538 | 0.030 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2018 | 501 | 0.030 |
Why?
|
Prosthesis Design | 1 | 2023 | 2115 | 0.030 |
Why?
|
Tissue Scaffolds | 1 | 2022 | 932 | 0.030 |
Why?
|
Propensity Score | 2 | 2015 | 1913 | 0.030 |
Why?
|
Waist-Hip Ratio | 1 | 2017 | 518 | 0.030 |
Why?
|
Mice, Nude | 1 | 2002 | 3604 | 0.030 |
Why?
|
Hypertriglyceridemia | 1 | 2018 | 293 | 0.030 |
Why?
|
Sirtuin 1 | 1 | 2017 | 246 | 0.030 |
Why?
|
Antirheumatic Agents | 1 | 2005 | 1366 | 0.030 |
Why?
|
Inguinal Canal | 3 | 1999 | 71 | 0.030 |
Why?
|
HeLa Cells | 1 | 2021 | 3073 | 0.030 |
Why?
|
Growth Hormone | 1 | 2017 | 569 | 0.030 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2017 | 361 | 0.030 |
Why?
|
Gingiva | 1 | 2017 | 410 | 0.030 |
Why?
|
Quality of Life | 1 | 2016 | 13362 | 0.030 |
Why?
|
Workload | 1 | 2020 | 844 | 0.030 |
Why?
|
Cardiovascular Diseases | 2 | 2013 | 15513 | 0.030 |
Why?
|
Peptide Hydrolases | 1 | 2017 | 616 | 0.030 |
Why?
|
Physical Conditioning, Animal | 1 | 2018 | 366 | 0.030 |
Why?
|
Blood Cell Count | 1 | 1995 | 396 | 0.030 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 619 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2021 | 1837 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2010 | 4308 | 0.030 |
Why?
|
Blood Pressure | 3 | 2021 | 8478 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2017 | 1535 | 0.030 |
Why?
|
Fluorescent Dyes | 1 | 2002 | 1902 | 0.030 |
Why?
|
Algorithms | 2 | 2006 | 14023 | 0.030 |
Why?
|
Actins | 1 | 2001 | 2046 | 0.030 |
Why?
|
Single-Blind Method | 2 | 2008 | 1577 | 0.030 |
Why?
|
Biliary Tract Diseases | 1 | 1994 | 159 | 0.030 |
Why?
|
Yeasts | 1 | 2014 | 279 | 0.030 |
Why?
|
Paracrine Communication | 1 | 2015 | 276 | 0.030 |
Why?
|
Mice, Inbred DBA | 1 | 2014 | 623 | 0.030 |
Why?
|
Health Services Needs and Demand | 1 | 2021 | 1401 | 0.030 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2017 | 597 | 0.030 |
Why?
|
Hospital Mortality | 3 | 2021 | 5296 | 0.030 |
Why?
|
Matrix Metalloproteinase 12 | 1 | 2012 | 44 | 0.030 |
Why?
|
Hirudins | 1 | 1994 | 179 | 0.030 |
Why?
|
Cell Adhesion | 2 | 2004 | 3090 | 0.030 |
Why?
|
Statistics, Nonparametric | 2 | 2012 | 2855 | 0.030 |
Why?
|
Bacterial Adhesion | 1 | 1993 | 304 | 0.030 |
Why?
|
Cooperative Behavior | 1 | 2019 | 1505 | 0.020 |
Why?
|
Computer Simulation | 3 | 2014 | 6225 | 0.020 |
Why?
|
Forecasting | 3 | 2013 | 2928 | 0.020 |
Why?
|
Angiography | 3 | 2005 | 1597 | 0.020 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2014 | 371 | 0.020 |
Why?
|
Dietary Carbohydrates | 1 | 2017 | 891 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2017 | 1702 | 0.020 |
Why?
|
Kidney Diseases | 1 | 2002 | 2092 | 0.020 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2014 | 420 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2017 | 1186 | 0.020 |
Why?
|
DNA Damage | 1 | 2021 | 2443 | 0.020 |
Why?
|
Receptors, Leptin | 1 | 2012 | 350 | 0.020 |
Why?
|
Antibodies, Monoclonal | 2 | 2005 | 9185 | 0.020 |
Why?
|
Dilatation, Pathologic | 1 | 2012 | 527 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20600 | 0.020 |
Why?
|
Area Under Curve | 1 | 2015 | 1636 | 0.020 |
Why?
|
Genes | 1 | 1995 | 1820 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2015 | 1066 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2014 | 15308 | 0.020 |
Why?
|
Immunoblotting | 1 | 2014 | 1644 | 0.020 |
Why?
|
Rats, Inbred Strains | 2 | 1989 | 2087 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2011 | 14676 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2017 | 1113 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2020 | 2316 | 0.020 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2014 | 1435 | 0.020 |
Why?
|
Cysteine | 1 | 2014 | 888 | 0.020 |
Why?
|
Warfarin | 1 | 1998 | 1482 | 0.020 |
Why?
|
Intestinal Diseases | 1 | 1994 | 503 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2004 | 3416 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2014 | 12145 | 0.020 |
Why?
|
Angiotensin II | 1 | 2012 | 848 | 0.020 |
Why?
|
Biocompatible Materials | 1 | 2018 | 1684 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2019 | 1790 | 0.020 |
Why?
|
Electric Impedance | 1 | 2014 | 756 | 0.020 |
Why?
|
Radiography | 3 | 2003 | 6975 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2017 | 1932 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15845 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 26068 | 0.020 |
Why?
|
Microdissection | 1 | 2009 | 151 | 0.020 |
Why?
|
Smad2 Protein | 1 | 2009 | 144 | 0.020 |
Why?
|
Hospital Charges | 2 | 2001 | 350 | 0.020 |
Why?
|
Smad3 Protein | 1 | 2009 | 166 | 0.020 |
Why?
|
Cortisone | 1 | 1989 | 87 | 0.020 |
Why?
|
Databases as Topic | 1 | 2011 | 473 | 0.020 |
Why?
|
Biological Evolution | 1 | 2014 | 1075 | 0.020 |
Why?
|
Liver Circulation | 1 | 1989 | 159 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3409 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2013 | 2262 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 1995 | 1987 | 0.020 |
Why?
|
Creatinine | 1 | 2014 | 1897 | 0.020 |
Why?
|
Staphylococcus aureus | 2 | 1993 | 1450 | 0.020 |
Why?
|
Fibrinolytic Agents | 2 | 1998 | 2075 | 0.020 |
Why?
|
Splenorenal Shunt, Surgical | 1 | 1988 | 15 | 0.020 |
Why?
|
Metabolomics | 1 | 2017 | 1658 | 0.020 |
Why?
|
Cell Communication | 1 | 2015 | 1650 | 0.020 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1989 | 818 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2000 | 9518 | 0.020 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2009 | 302 | 0.020 |
Why?
|
Life Expectancy | 1 | 2014 | 1242 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2017 | 2057 | 0.020 |
Why?
|
Transfection | 1 | 2015 | 5750 | 0.020 |
Why?
|
Resource Allocation | 1 | 2010 | 350 | 0.020 |
Why?
|
Skin | 1 | 2001 | 4473 | 0.020 |
Why?
|
Proteomics | 1 | 2021 | 3836 | 0.020 |
Why?
|
Antibodies | 1 | 2015 | 2415 | 0.020 |
Why?
|
Fistula | 1 | 1989 | 212 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2019 | 3450 | 0.020 |
Why?
|
Hot Temperature | 1 | 1993 | 1434 | 0.020 |
Why?
|
Adiposity | 1 | 2017 | 1879 | 0.020 |
Why?
|
Fourier Analysis | 1 | 1988 | 439 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2014 | 2637 | 0.020 |
Why?
|
Blood Volume | 1 | 1988 | 547 | 0.020 |
Why?
|
Adult | 8 | 2019 | 221083 | 0.020 |
Why?
|
Membrane Fluidity | 1 | 1986 | 67 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2014 | 2025 | 0.020 |
Why?
|
Postoperative Period | 1 | 2010 | 1818 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 2009 | 1097 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 2014 | 1711 | 0.020 |
Why?
|
Microvilli | 1 | 1986 | 234 | 0.020 |
Why?
|
Caenorhabditis elegans | 1 | 2014 | 1455 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2010 | 11118 | 0.020 |
Why?
|
Stem Cells | 1 | 2018 | 3512 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2015 | 2892 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 2014 | 2193 | 0.010 |
Why?
|
Elasticity | 1 | 2007 | 655 | 0.010 |
Why?
|
Heart Diseases | 1 | 2017 | 2795 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2019 | 12341 | 0.010 |
Why?
|
Staphylococcal Infections | 1 | 1993 | 1400 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2014 | 2682 | 0.010 |
Why?
|
Ovary | 1 | 1989 | 957 | 0.010 |
Why?
|
Aging | 2 | 2017 | 8701 | 0.010 |
Why?
|
Blood Platelets | 1 | 1995 | 2477 | 0.010 |
Why?
|
Compliance | 1 | 2003 | 99 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3803 | 0.010 |
Why?
|
Rheology | 1 | 2004 | 347 | 0.010 |
Why?
|
Mechanotransduction, Cellular | 1 | 2008 | 528 | 0.010 |
Why?
|
Retroperitoneal Space | 1 | 2003 | 170 | 0.010 |
Why?
|
Anticoagulants | 1 | 1998 | 4795 | 0.010 |
Why?
|
Insulin | 1 | 2017 | 6588 | 0.010 |
Why?
|
Fibrosis | 1 | 2009 | 2051 | 0.010 |
Why?
|
Prognosis | 2 | 2014 | 29672 | 0.010 |
Why?
|
Renal Circulation | 1 | 2002 | 291 | 0.010 |
Why?
|
Reference Values | 1 | 1989 | 4922 | 0.010 |
Why?
|
Gene Deletion | 1 | 2009 | 2656 | 0.010 |
Why?
|
Tissue and Organ Procurement | 1 | 2010 | 962 | 0.010 |
Why?
|
Kinetics | 1 | 1989 | 6312 | 0.010 |
Why?
|
Leukocytes | 1 | 2009 | 2024 | 0.010 |
Why?
|
Young Adult | 3 | 2013 | 59199 | 0.010 |
Why?
|
Laparotomy | 1 | 2003 | 456 | 0.010 |
Why?
|
Neutrophils | 1 | 1993 | 3763 | 0.010 |
Why?
|
Axillary Artery | 1 | 2000 | 47 | 0.010 |
Why?
|
Health Status | 1 | 2014 | 4077 | 0.010 |
Why?
|
Mice, Inbred NOD | 1 | 2004 | 1822 | 0.010 |
Why?
|
Research | 1 | 2008 | 1975 | 0.010 |
Why?
|
Random Allocation | 1 | 2004 | 2393 | 0.010 |
Why?
|
Neoplasms | 1 | 2008 | 22125 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2011 | 20120 | 0.010 |
Why?
|
Massachusetts | 1 | 2012 | 8836 | 0.010 |
Why?
|
Phosphorylation | 1 | 2009 | 8303 | 0.010 |
Why?
|
Florida | 1 | 1999 | 429 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 1989 | 3030 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2015 | 11505 | 0.010 |
Why?
|
Probability | 1 | 2003 | 2478 | 0.010 |
Why?
|
Splanchnic Circulation | 1 | 1997 | 119 | 0.010 |
Why?
|
Glucocorticoids | 1 | 1986 | 2160 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15717 | 0.010 |
Why?
|
Perioperative Care | 1 | 2003 | 1037 | 0.010 |
Why?
|
Hospitals, General | 1 | 1999 | 798 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2005 | 5870 | 0.010 |
Why?
|
Chromogenic Compounds | 1 | 1994 | 30 | 0.010 |
Why?
|
Spinal Cord Injuries | 1 | 2002 | 924 | 0.010 |
Why?
|
alpha 1-Antitrypsin | 1 | 1995 | 167 | 0.010 |
Why?
|
Plasminogen | 1 | 1994 | 143 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1995 | 1053 | 0.010 |
Why?
|
Confidence Intervals | 1 | 1999 | 2927 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2004 | 5478 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1995 | 1544 | 0.010 |
Why?
|
Textiles | 1 | 1993 | 45 | 0.010 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 1993 | 199 | 0.010 |
Why?
|
Creatine Kinase | 1 | 1995 | 684 | 0.010 |
Why?
|
Child | 1 | 2021 | 80134 | 0.010 |
Why?
|
Research Design | 1 | 2008 | 6178 | 0.010 |
Why?
|
Retinoblastoma | 1 | 1995 | 319 | 0.010 |
Why?
|
Dipeptides | 1 | 1994 | 387 | 0.010 |
Why?
|
Actuarial Analysis | 1 | 1992 | 372 | 0.010 |
Why?
|
Aorta | 1 | 1999 | 2040 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2010 | 9278 | 0.010 |
Why?
|
Data Collection | 1 | 2001 | 3319 | 0.010 |
Why?
|
Thrombin | 1 | 1994 | 593 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1995 | 1989 | 0.010 |
Why?
|
Heparin | 1 | 1998 | 1632 | 0.010 |
Why?
|
Cross-Linking Reagents | 1 | 1994 | 684 | 0.010 |
Why?
|
Coloring Agents | 1 | 1993 | 562 | 0.010 |
Why?
|
Substrate Specificity | 1 | 1994 | 1768 | 0.010 |
Why?
|
Heart Failure | 1 | 2014 | 11701 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1995 | 4168 | 0.010 |
Why?
|
Survival Analysis | 1 | 2001 | 10083 | 0.000 |
Why?
|
Oligopeptides | 1 | 1994 | 1178 | 0.000 |
Why?
|
Hospitals | 1 | 2001 | 3881 | 0.000 |
Why?
|
Aspirin | 1 | 1998 | 3128 | 0.000 |
Why?
|
Microbial Sensitivity Tests | 1 | 1993 | 1936 | 0.000 |
Why?
|
Diphenylhexatriene | 1 | 1986 | 12 | 0.000 |
Why?
|
Interferon-gamma | 1 | 1995 | 3155 | 0.000 |
Why?
|
alpha-Glucosidases | 1 | 1986 | 45 | 0.000 |
Why?
|
Fluorescence Polarization | 1 | 1986 | 140 | 0.000 |
Why?
|
Polymerase Chain Reaction | 1 | 1995 | 6067 | 0.000 |
Why?
|
Base Sequence | 1 | 1995 | 12404 | 0.000 |
Why?
|
Maternal-Fetal Exchange | 1 | 1986 | 461 | 0.000 |
Why?
|
Health Services Accessibility | 1 | 1999 | 5427 | 0.000 |
Why?
|
Protein Binding | 1 | 1994 | 9300 | 0.000 |
Why?
|
Transcription, Genetic | 1 | 1995 | 7574 | 0.000 |
Why?
|
Animals, Newborn | 1 | 1986 | 2666 | 0.000 |
Why?
|
Temperature | 1 | 1986 | 2219 | 0.000 |
Why?
|
Dexamethasone | 1 | 1986 | 1945 | 0.000 |
Why?
|
Hydrocortisone | 1 | 1986 | 1818 | 0.000 |
Why?
|
Gestational Age | 1 | 1986 | 3577 | 0.000 |
Why?
|
Child, Preschool | 1 | 1992 | 42217 | 0.000 |
Why?
|
Pregnancy | 1 | 1986 | 29872 | 0.000 |
Why?
|